KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells

American Journal of Physiology - Cell Physiology

Volumn 276, Issue 1 45-1, 1999, Pages

  Cunningham, Sonia A ^a,b   Tran, Tuan M ^a   Arrate, M Pia ^a   Bjercke, Robert ^a   Brock, Tommy A ^a  

^a TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Kinase insert domain containing receptor; Neutralizing antibodies; Tyrosine kinase; Vascular endothelial cell growth factor

Indexed keywords

CALCIUM ION; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS; UMBILICAL VEIN;

EID: 0032923909     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1999.276.1.c176     Document Type: Article

References (15)

1. Abedi, H., and I. Zachary. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272: 15442-15451, 1997.
2. Aiello, L. P., S. E. Bursell, A. Clermont, E. Duh, H. Ishii, C. Takagi, F. Mori, T. A. Ciulla, K. Ways, M. Jirousek, L. E. Smith, and G. L. King. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46: 1473-1480, 1997.
3. Barleon, B., S. Sozzani, D. Zhou, H. A. Weich, A. Mantovani, and D. Marine. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343, 1996.
4. Barleon, B., F. Totzke, C. Herzog, S. Blanke, E. Kremmer, G. Siemeister, D. Marme and Martiny-Baron. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor Flt-1. J. Biol. Chem. 272: 10382-10388, 1997.
5. Cao, Y., H. Chen, L. Zhou, M.-K. Chiang, B. Anand-Apte, J. A. Weatherbee, Y. Wang, F. Fang, J. G. Flanagan, and M. L.-S. Tsang. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J. Biol. Chem. 271: 3154-3162, 1995.
6. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
7. Carpenter, G., and S. Cohen. Epidermal growth factor. J. Biol. Chem. 265: 7709-7712, 1990.
8. Clauss, M., H. Weich, G. Breier, U. Knies, W. Rockl, J. Waltenberger, and W. Risau. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271: 17629-17634, 1996.
9. Couet, J., M. Sargiacomo, and L. P. Lisanti. Interaction of receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272: 30429-30438, 1997.
10. Cunningham, S. A., M. P. Arrate, T. A. Brock, and M. N. Waxham. Interactions of Flt-1 and KDR with phospholipase C γ: identification of the phosphotyrosine binding sites. Biochem. Biophys. Res. Commun. 240: 635-639, 1997.
11. Cunningham, S. A., C. S. Stephan, M. P. Arrate. K. G. Ayer, and T. A. Brock. Identification of the extracellular domains of Flt-1 that mediate ligand interactions. Biochem. Biophys. Res. Commun. 231: 596-599, 1997.
12. Davis-Smyth, T., H. Chen, J. Park, L. G. Presta, and N. Ferrara. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15: 4919-4927, 1996.
13. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan, and M. W. Moore. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
14. Fong, G.-H., J. Rossant, M. Gertsenstein, and M. L. Breitrnan. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995.
15. Kaplan, J. B., L. Sridharan, J. A. Zaccardi, M. Dougher-Vermazen, and B. I. Terman. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera. Growth Factors 14: 243-256, 1997.